U.S. Markets
Humana (HUM) says its 2027 Medicare Advantage bid strategy is expected to drive solid progress toward a sustainable pre-tax margin of at least 3% in 2027
StockNow breaking-news AI analysis
Humana is pivoting to a profitability-first strategy, targeting a 3% Medicare Advantage margin by 2027 through disciplined bidding and cost management despite current high medical utilization pressures.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
